ONCOLOGY

Intervention improves focused symptom areas, but not overall symptoms.

By activating the bacterial SOS response, chemotherapy treatments promote antibiotic resistance and bacterial translocation.

The treatment will be available within the Cancer Drugs Fund

It includes two updated recommendations.

DART trial shows no PFS benefit in advanced clear-cell renal carcinoma.

Results from the multi-national SAUL trial.

High positive predictive value, detection rate, reproducibility.

The draft guideline is open for public comment until 18 April 2019

Survival benefit seen in patients with thrombus above the diaphragm.

Findings from IMvigor211 are applicable to a broader, pretreated population.

Stereotactic body radiation therapy was well tolerated in patients.

Reductions in mortality driven by lung cancer in men, breast cancer in women.

PROPHECY data link AR-V7 presence in circulating tumor cells to poor survival.

Trial was terminated early because of futility.